On October 31st, the 6th Cailian Press ESG Forum, guided by Shanghai United Media Group and hosted by Cailian Press, concluded successfully in Beijing. The event gathered representatives from government departments, academic institutions, listed companies, and financial organizations to conduct in-depth exchanges on ESG development, sharing cutting-edge solutions and successful practices. Amidst the concurrent "Zhiyuan Awards" ceremony, INTCO Medical—the largest latex-free nitrile gloves manufacturer—was honored with the prestigious "2025 Cailian Press Zhiyuan Award - ESG Pioneer Enterprise" for its outstanding performance across all ESG evaluation dimensions. This recognition further solidifies the company’s leading position in sustainable development within the global medical industry.
	
	
 
	
INTCO Medical’s Consistent ESG Excellence and Industry Leadership
As a global leader in the disposable gloves sector, INTCO Medical has released annual ESG reports consecutively since 2021, earning widespread acclaim for its sustainability capabilities. In 2024, the company was awarded the EcoVadis "COMMITTED" badge—a testament to its rigorous environmental, social, and governance standards—and ranked among the "Top 20 ESG Listed Medical Device Companies in A-Shares 2024". Building on this momentum, 2025 brought additional milestones: INTCO Medical obtained dual certifications in Life Cycle Assessment (LCA) and Carbon Footprint, and was included in S&P Global’s "Sustainability Yearbook (China Edition) 2025". Its commitment to ESG has also been validated by leading rating agencies—maintaining an A-level rating from Wind ESG and achieving an upgraded BBB-level rating from MSCI ESG, reflecting its continuous improvement in sustainable governance.
	
Comprehensive ESG Practices: From Strategy to Action
Core Sustainability Commitments and Green Initiatives
Sustainable development is at the heart of INTCO Medical’s corporate strategy. The company has set ambitious climate targets: reducing carbon emissions per glove by 25% by 2030 (based on 2022 levels) and achieving carbon neutrality within its own operations by 2050.
	
INTCO Medical has also made significant strides in adopting clean energy. Its photovoltaic power generation reached 3.538 million kilowatt-hours in 2024, and wind power infrastructure, constructed the same year, began operations in 2025. These initiatives align with global efforts to transition to renewable energy sources, as advocated by international sustainability guidelines.
	
Innovation-Driven Smart Manufacturing
Innovation serves as the engine of INTCO Medical’s growth, with the company continuously deepening its expertise in three core business segments: medical consumables, rehabilitation equipment, and physical therapy. In 2024, the company invested 398 million RMB in research and development, launching 55 new products—representing a 197% increase compared to 2023. This commitment to innovation is further enhanced by the integration of automation and AI technologies, as INTCO Medical accelerates its "smart manufacturing upgrade" to meet the diverse needs of global customers.
	
The company’s focus on quality and innovation is underscored by its compliance with international standards, including FDA regulations for medical devices. Its status as the largest latex-free nitrile gloves manufacturer is reinforced by its ability to deliver reliable, high-performance products that meet the strict requirements of healthcare providers worldwide.
	
Responsible Supply Chain Management
INTCO Medical has established a robust supply chain management system, emphasizing ESG risk management and supply chain resilience. In 2024, the company organized 198 training sessions and 268 technical seminars for suppliers, providing support for improvement plans across 1,100 supplier partners. This collaborative approach ensures that sustainability principles are adopted throughout the value chain, from raw material sourcing to product delivery.
	
The company’s supplier engagement initiatives align with best practices outlined in MSCI’s ESG rating framework, which emphasizes supply chain transparency and responsible sourcing. By empowering suppliers with the tools and knowledge to improve their ESG performance, INTCO Medical is building a more sustainable and resilient industry ecosystem.
	
Social Welfare and Employee-Centric Culture
As of the end of 2024, INTCO Medical has donated over 75.82 million RMB to social welfare initiatives, supporting communities in need and promoting public health. The company views talent as its core asset, striving to create a fair, inclusive, and human rights-respecting work environment.
	
	
 
	
Employee well-being is a key priority, with INTCO Medical’s facilities hosting weekly Saturday afternoon tea sessions, festival celebrations (including Lantern Festival, International Women’s Day, and Christmas), and birthday parties for staff. The company also organizes staff trips—50 overseas batches and 8 domestic batches—to foster team spirit and work-life balance. These initiatives reflect the company’s commitment to social responsibility and employee care, as highlighted in its corporate overview.
	
Brand Collaboration: ESG Values Through Co-Branded Gift Box
At the forum, INTCO Medical collaborated with Cailian Press to launch a co-branded "Zhangting Pioneer" gift box as a souvenir for event guests. The box included two custom products—eye masks and face masks—showcasing the company’s professional strengths in protective products while embodying the brand concepts of "health protection" and "sustained growth". This thoughtful gift provided guests with a tangible brand experience, further enhancing INTCO Medical’s image and influence in the industry and capital markets.
	
Looking Ahead: A New Starting Point for Sustainable Leadership
Winning the "2025 Cailian Press Zhiyuan Award - ESG Pioneer Enterprise" is not an end but a new beginning for INTCO Medical. As the largest latex-free nitrile gloves manufacturer, the company remains committed to addressing the era’s sustainability challenges through concrete actions. It will continue to lead by example, setting benchmarks for ESG excellence in the medical consumables industry and driving positive change across the global value chain.
	
                
                